2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Autor: Matthias Antz, Hein Heidbuchel, Jan Steffel, Mellanie True Hills, Boyoung Joung, Vanessa Roldan-Schilling, Giuseppe Boriani, Nigel Rowell, Jonas Oldgren, T. Deneke, External reviewers, Gregory Y.H. Lip, Karl Georg Haeusler, Tatjana S. Potpara, Tze-Fan Chao, Mark Field, Thomas Vanassche, Peter Sinnaeve, Pieter Cornu, Ronan Collins, A. John Camm, Oana Maria Cole, Deirdre A. Lane, Eue Keun Choi, Holger Reinecke, Lien Desteghe, Dan Atar, Itamar S. Santos, Nikolaos Dagres

Publikováno v: Europace
Steffel, J, Collins, R, Antz, M, Cornu, P, Desteghe, L, Haeusler, K G, Oldgren, J, Reinecke, H, Roldan-Schilling, V, Rowell, N, Sinnaeve, P, Vanassche, T, Potpara, T, Camm, A J, Heidbüchel, H, External reviewers:, Lip, G Y H, Deneke, T, Dagres, N, Boriani, G, Chao, T-F, Choi, E-K, Hills, M T, Santos, I D S, Lane, D A, Atar, D, Joung, B, Cole, O M & Field, M 2021, ' 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation ', Europace, vol. 23, no. 10, pp. 1612-1676 . https://doi.org/10.1093/europace/euab065

Bayer Pharma AG; Bristol-Myers SquibbBristol-Myers Squibb; Pfizer Alliance; DaiichiSankyo Europe GmbHDaiichi Sankyo Company Limited

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9fa0ea86a73b5b845a8bf6c9ca570ca
https://hdl.handle.net/11380/1251508